(+)-4-Propyl-9-hydroxynaphthoxazine ((+)PHNO) is a high affinity, preferential dopamine D-3 versus D-2 agonist employed in view of its high specificity and excellent signal-to-noise ratio as a radiotracer for positron emission tomography (PET) imaging. Surprisingly, its profile at other classes of monoamine receptor remains undocumented. In addition to hD(3) and hD(2L) receptors, (+)PHNO revealed high affinity at hD(4.4) but not hD(1) or hD(5) receptors. It also revealed significant affinity for several other G protein-coupled monoaminergic receptors, in particular h5-HT1A and h5-HT7. (+)PHNO behaved as a full agonist at hD(4.4) and h5-HT1A receptors with potencies comparable to its actions at hD(3) and hD(2L) receptors, and with less potency at 5-HT7 receptors. In binding assays with membranes derived from cells co-expressing hD(3) and hD(2L) receptors and labeled with [H-3]Nem-onapride or [H-3]Spiperone, the proportion of high affinity binding sites recognized by (+)PHNO was higher than an equivalent mixture of membranes from cells expressing hD(3) or hD(2L) receptors, suggesting that (+)PHNO promotes formation of hD(3)-hD(2L) heterodimers. Further, in cells co-expressing hD(3) and hD2L receptors, (+)PHNO showed higher efficacy for inhibiting forskolin stimulated adenylyl cyclase and inducing adenylyl cyclase super sensitization than in cells transfected with only hD(2L) receptors. In conclusion, (+)PHNO is a potent agonist at hD(4.4), h5-HT1A and h5-HT7 as well as hD(3) and hD(2L) receptors, and it potently activates dopamine hD(3)-hD(2L) heterodimers. These interactions should be considered when interpreting PET studies with [C-11](+)PHNO and may be relevant to its functional and potential clinical properties in Parkinson's disease and other disorders.

Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging

Petragnano, Francesco
Investigation
;
Fasciani, Irene
Investigation
;
Aloisi, Gabriella
Methodology
;
Carli, Marco
Membro del Collaboration Group
;
Rossi, Mario
Conceptualization
;
Marampon, Francesco
Conceptualization
;
Maggio, Roberto
Conceptualization
2022-01-01

Abstract

(+)-4-Propyl-9-hydroxynaphthoxazine ((+)PHNO) is a high affinity, preferential dopamine D-3 versus D-2 agonist employed in view of its high specificity and excellent signal-to-noise ratio as a radiotracer for positron emission tomography (PET) imaging. Surprisingly, its profile at other classes of monoamine receptor remains undocumented. In addition to hD(3) and hD(2L) receptors, (+)PHNO revealed high affinity at hD(4.4) but not hD(1) or hD(5) receptors. It also revealed significant affinity for several other G protein-coupled monoaminergic receptors, in particular h5-HT1A and h5-HT7. (+)PHNO behaved as a full agonist at hD(4.4) and h5-HT1A receptors with potencies comparable to its actions at hD(3) and hD(2L) receptors, and with less potency at 5-HT7 receptors. In binding assays with membranes derived from cells co-expressing hD(3) and hD(2L) receptors and labeled with [H-3]Nem-onapride or [H-3]Spiperone, the proportion of high affinity binding sites recognized by (+)PHNO was higher than an equivalent mixture of membranes from cells expressing hD(3) or hD(2L) receptors, suggesting that (+)PHNO promotes formation of hD(3)-hD(2L) heterodimers. Further, in cells co-expressing hD(3) and hD2L receptors, (+)PHNO showed higher efficacy for inhibiting forskolin stimulated adenylyl cyclase and inducing adenylyl cyclase super sensitization than in cells transfected with only hD(2L) receptors. In conclusion, (+)PHNO is a potent agonist at hD(4.4), h5-HT1A and h5-HT7 as well as hD(3) and hD(2L) receptors, and it potently activates dopamine hD(3)-hD(2L) heterodimers. These interactions should be considered when interpreting PET studies with [C-11](+)PHNO and may be relevant to its functional and potential clinical properties in Parkinson's disease and other disorders.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11697/195246
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact